Sciatica Treatment Market Size, Share & COVID-19 Impact Analysis, By Type (Acute and Chronic), By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Antidepressants, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2023-2030

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI108950

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2017-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2017-2021
Growth Rate	CAGR of 10.2% from 2023-2030
Unit	Value (USD Billion)
Segmentation	By Type Acute Chronic
	By Drug Class Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Corticosteroids Antidepressants Others
	By Distribution Channel Hospital Pharmacies Retail & Online Pharmacies
	By Region North America (By Type, Drug Class, Distribution Channel, and Country) U.S. Canada Europe (By Type, Drug Class, Distribution Channel, and Country/Sub-Region) U.K. Germany France Italy Spain Rest of Europe Asia Pacific (By Type, Drug Class, Distribution Channel, and Country/Sub-Region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Type, Drug Class, Distribution Channel, and Country/Sub-Region) Brazil Mexico Rest of Latin America Middle East & Africa (By Type, Drug Class, Distribution Channel, and Country/Sub-Region) GCC South Africa Rest of the Middle East & Africa